One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques that can be ‘decentralized,’ in other words accessed by populations and countries with limited resources. Scientists have now developed and validated a rapid, reliable, point-of-care HCV assay.